Cape Investment Advisory, Inc. Sarepta Therapeutics, Inc. Transaction History
Cape Investment Advisory, Inc.
- $274 Billion
- Q2 2025
A detailed history of Cape Investment Advisory, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 26 shares of SRPT stock, worth $604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$604% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
449Shares Held
83MCall Options Held
5.6MPut Options Held
4.17M-
Black Rock Inc. New York, NY10.3MShares$240 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$213 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$109 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$104 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$58.8 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $2.04B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...